SCHEMBL7652677

SCHEMBL7652677

O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1c[nH]c2cc(F)cc(F)c12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.50
CYP2C19 P33261 5/20 0.46
CYP2D6 P10635 3/20 0.46
CYP3A4 P08684 3/20 0.44
RAB9A P51151 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2B6 P20813 1/20 0.44
KCNH2 Q12809 1/20 0.44
POLB P06746 1/20 0.44
TP53 P04637 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALOX15 P16050 1/20 0.43
LMNA P02545 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4247829 0.86 CYP2C9 (0.52) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL12152012 0.86 POLB (0.39) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL12151935 0.84 POLB (0.38) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL7657629 0.83 CYP2C19 (0.54) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL6442505 0.79 CYP2C9 (0.56) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL6442889 0.78 CYP2C9 (0.55) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL3843612 0.77 POLB (0.71) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL7651570 0.77 CYP2C9 (0.52) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A
SCHEMBL13325449 0.77 CYP2D6 (0.41) CYP2C9CYP2C19CYP2D6RAB9AKCNH2
SCHEMBL12215153 0.77 CYP2C9 (0.54) CYP2C9CYP2C19CYP2D6CYP3A4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469006-B1 PARTICULARLY FOR TREATING HIV INFECTIONS BRISTOL-MYERS SQUIBB COMPANY 2002-10-22 US disclosed
EP-1105135-A4 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2001-12-12 EP disclosed
EP-1105135-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-06-13 EP disclosed
WO-2000076521-A1 ANTIVIRAL INDOLEOXOACETYL PIPERAZINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-12-21 WO disclosed